Acute Myocardial Infarction
Early abciximab administration improves myocardial salvage and left ventricular function
Published in Drug Week, May 26th, 2006
According to a study from Italy, "Glycoprotein IIb/IIIa inhibitors improve myocardial reperfusion and clinical outcomes of patients with acute myocardial infarction undergoing primary percutaneous coronary intervention, but optimal timing of administration remains unclear. In this prospective randomized trial, we evaluated the impact of early abciximab administration on angiographic findings, myocardial salvage, and left ventricular function.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2006-05-26)
More Articles from Drug Week
- Atherosclerosis
ISIS 301012 reduces atherosclerotic plaques in animal models, data suggests - Drug Development
Alexza initiates AZ-003 phase I clinical trial for anti-pain drug - Drug Development
Alfacell provides update on onconase phase IIIb trial - Drug Development
Alnylam presents phase I data for ALN-RSV01 - HIV/AIDS Drug Development
Oxindole inhibits HIV-1 reverse transcriptase - Adenocarcinoma
Lung adenocarcinoma cells may be targeted by short hairpin RNA targeting EGFR - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
